Cansino Biologics Inc (688185) Stock Price & News

688185:SHA

Cansino Biologics Inc

CN¥66.05

+2.59%

(+1.67) 1D

Sep 17, 3:00:03 PM GMT+8 · CNY

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 688185...

Open

CN¥64.05

High

CN¥68.98

Low

CN¥63.92

Mkt. cap

10.14B

Avg. vol.

8.02M

Volume

9.64M

P/E ratio

336.84

52-wk high

CN¥96.52

52-wk low

CN¥46.89

EPS

CN¥0.20

No. of employees

Open

CN¥64.05

High

CN¥68.98

Low

CN¥63.92

Mkt. cap

10.14B

Avg. vol.

8.02M

Volume

9.64M

P/E ratio

336.84

52-wk high

CN¥96.52

52-wk low

CN¥46.89

EPS

CN¥0.20

No. of employees

Related stocks

600874

Tianjin Capital Environmental Protection Ord Shs A

CN¥5.54

-0.18%

002821

Asymchem Laboratories (Tianjin) Co Ltd

CN¥186.23

+2.06%

601588

Beijing North Star Ord Shs A

CN¥1.69

+1.20%

605198

Yantai North Andre Juice Co Ltd

CN¥79.85

-1.84%

News stories

From web sources and news partners

TipRanks

1 day ago

CanSino Biologics Grants Reserved Restricted Shares Under 2025 Incentive Scheme

Profile

CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia

About Cansino Biologics Inc

CEOXuefeng Yu

Employees1.13K

FoundedJan 13, 2009

Headquarters-

SectorBiotechnology

Websitecansinotech.com

All values in CNY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	310.24M	375.34M	190.28M	359.54M
Cost of goods sold	55.37M	129.82M	36.26M	90.95M
Cost of revenue	55.37M	129.82M	36.26M	90.95M
Research and development expenses	76.87M	88.37M	71.41M	84.08M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	158.60M	187.81M	116.85M	158.72M
Operating expense	218.49M	325.84M	182.92M	230.92M
Total operating expenses	273.86M	455.66M	219.19M	321.87M
Operating income	36.38M	-80.32M	-28.90M	37.67M
Other non operating income	-8.06M	5.34M	-9.91M	-9.09M
EBT including unusual items	27.79M	13.25M	-34.38M	40.42M
EBT excluding unusual items	40.15M	-74.47M	-36.57M	35.50M
Income tax expense	-134.75K	-181.72K	6.04M	714.36K
Effective tax rate	-0.48%	-1.37%	-17.58%	1.77%
Other operating expenses	-15.79M	50.87M	-9.21M	-17.19M
Net income	27.93M	13.43M	-40.42M	39.70M
Net profit margin	9.00%	3.58%	-21.24%	11.04%
Earnings per share	-	-	-	-
Interest and investment income	13.97M	21.09M	9.43M	12.84M
Interest expense	-11.11M	-3.20M	-7.19M	-5.91M
Net interest expenses	2.86M	17.88M	2.24M	6.92M
Depreciation and amortization charges	-	-	-	-
EBITDA	82.74M	-39.25M	12.18M	84.20M
Gain or loss from assets sale	84.72K	-137.05K	-	-

Finance

Ask anything